TechFlex is dedicated to assisting startups in the Series A and Seed money stages to achieve their objectives through a structured and supportive framework. Our approach focuses on providing tailored solutions that address the unique challenges faced by early-stage companies.
TechFlex is the catalyst for success in the medical device industry, offering comprehensive support to growing companies. With expertise spanning from initial concept to market entry, TechFlex provides tailored solutions, cutting-edge technologies, and regulatory guidance.
Q’Apel Medical has announced the receipt of US Food and Drug Administration (FDA) clearance for its Zebra neurovascular access system, with a full US launch of the device now being prepared. Available in 6Fr and 7Fr sizes, Zebra is indicated for the introduction of interventional devices into the…
Read the full article at: neuronewsinternational.com
